Home
/ Cullgen
/ Competitors

Cullgen Competitors and Similar CompaniesClear all

Cullgen's competitors and similar companies include NextCure, Kite Pharma, Karo Healthcare and Ayala Pharmaceuticals.

	Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.	Kite Pharma Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.	Karo Healthcare Karo Healthcare is a healthcare company, which develops and markets products for pharmacies and the health care sectors.	Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.
Founding Date	Founding Date 2018	Founding Date 2015	Founding Date 2009	Founding Date 1987	Founding Date 2017
Type	Type Private	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Technology biotech drug development oncology pharma therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare Technology biotech drug development life sciences oncology pharma therapy
Locations	Locations San Diego, US HQ Shanghai, CN Tokyo, JP	Locations Beltsville, US HQ	Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more	Locations Stockholm, SE HQ Stockholm, SE	Locations Wilmington, US HQ Rehovot, IL Wilmington, US
Employees	Employees 4	Employees N/A	Employees 3,9671% decrease	Employees 225	Employees 29
Valuation ($)	Valuation ($) N/A	Valuation ($) 39.2 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 7.4 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) kr3b (FY, 2021)	Revenue (est.) $692k (FY, 2022)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods kr1.3b (FY, 2021)	Cost of goods $602k (FY, 2022)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit kr1.7b (FY, 2021)	Gross profit $90k (FY, 2022)
Net income	Net income N/A	Net income ($55.8m) (FY, 2025)	Net income N/A	Net income (kr17m) (FY, 2021)	Net income ($38m) (FY, 2022)
Funding
Total funding raised	Total funding raised $ 31m	Total funding raised $ 160m	Total funding raised $ 85.3m	Total funding raised N/A	Total funding raised $ 47m